BUY THIS PRODUCTS FROM AMAZON.COM HERE

ANDIEZ You Don't Stop Judo When You Get Old You Get Old When You Stop Judo Poster

✅ Printed in the USA

✅ High-quality

✅ Order at amazon.com

ANDIEZ You Don't Stop Judo When You Get Old You Get Old When You Stop Judo Poster

 t really starts aligning the COVID vaccine with those vaccines that we already use in pregnant women like the flu vaccine," Dr. Neeta Ogden, an internal medicine specialist and immunologist, told CBSN on Wednesday. "We really need, and it is clear that we need, significant data on how safe it is in pregnant women." 

These early results ANDIEZ You Don't Stop Judo When You Get Old You Get Old When You Stop Judo Poster  may help give pregnant women more reason to consider getting the vaccine. 

"This also is hopeful because it offers a level of protection to one of the most vulnerable populations, the newborn," Ogden said, emphasizing the need to further study in pregnant women during this pandemic. 

Since we don't have COVID vaccines approved for children yet, she said, "If we can see this kind of safe maternal transmission of antibodies from the vaccine to newborns, I think that's really a great step in the right direction."

Other recent studies, also shared in preprint and not yet peer-reviewed, support the findings. 

Massachusetts General Hospital recently studied 131 women — 84 pregnant, 31 breastfeeding and 16 non-pregnant — who all received the Pfizer or Moderna vaccines. They found equally strong immune responses in the pregnant and lactating women as the control group. Additionally, antibodies were present in the placenta and breastmilk of every sample taken. 

"Maternal vaccine-generated antibodies were detected in the umbilical cord blood of all 10 babies who delivered during our study period," co-author Dr. Andrea Edlow, a maternal-fetal medicine specialist at Massachusetts General Hospital, told CBS News on Wednesday. "Our data suggest that receiving both shots of the mRNA vaccine leads to improved antibody transfer to newborns."

Another study out of Israel found antibodies in all 20 women tested who received both doses of the Pfizer vaccine, both during their third trimesters and in their newborns, also through placental transfer.

Last month, Pfizer announced that it had begun the first large-scale trial of its vaccine on pregnant women, which it expects to finish by the beginning of 2023. Its vaccine was approved for emergency use in the U.S. In December, and millions of people, including thousands of pregnant women, have taken it already.

Visit our Social Network: Pinterest, Blogger, and see more at our collection.